Close Menu

herpes

Quidel said last week that it has received 510(k) clearance from the US Food and Drug Administration for its AmpliVue HSV 1+2 assay for the differentiation of herpes simplex viruses 1 and 2.

NEW YORK (GenomeWeb News) – Quidel announced after the close of the market on Thursday the 510(k) clearance by the US Food and Drug Administration of the company's AmpliVue HSV 1+2 Assay for differentiating and detecting herpes simplex viruses 1 and 2.

NEW YORK (GenomeWeb News) – Quest Diagnostics today announced that its Focus Diagnostics business has received expedited 510(k) clearance from the US Food and Drug Administration and CLIA moderate complexity categorization for its Simplexa HSV 1&2 Direct molecular test on the 3M Integrated Cy

Focus Diagnostics, a Quest Diagnostics subsidiary, is aiming to receive US Food and Drug Administration approval in 2014 for a number of direct-from-specimen Simplexa-branded molecular diagnostic tests for the 3M Integrated Cycler, a company official said recently.

A team from Cornell University and Cornell Weill Medical College has received a grant from the National Institute of Biomedical Imaging and Bioengineering to support early clinical development and validation of its solar-powered, point-of-care PCR to enable electricity-free diagn

Researchers last week provided a glimpse of the clinical performance of a trio of extraction-free molecular assays currently being developed by clinical diagnostics firm Quidel.

Scientists from Cornell University and Cornell Weill Medical College are developing a solar-powered, point-of-care PCR system that has the potential to enable electricity-free molecular diagnostics in resource-poor areas of the world.

BioHelix is developing a low-cost, handheld, real-time fluorescence detection system capable of running assays based on the company's isothermal helicase-dependent amplification technology, the company disclosed this week.

IMDx said this week that it has received CE marking for its HSV-1/2 assay for use on the Abbott m2000 System.

Luminex this week made a play for the low- to mid-volume molecular diagnostic testing market by when it announced that it is acquiring privately held molecular diagnostics developer GenturaDx for $50 million.

Pages

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.